← Evidence map

TrialCancer immunology, immunotherapy : CII2021

CAR19/22 T cell therapy in adult refractory Burkitt's lymphoma.

Xiaoxi Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

20 papers cite it

2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 33459843